• Customer Service Team available now: Mon-Fri 8:00-17:00
Mounjaro KwikPen 2.5mg and 5mg placed in front of a calendar, measuring tape, and a glass of water
Short answer

Mounjaro starts affecting your appetite within days of the first injection.

Measurable weight loss usually follows over the first weeks to months, because the dose is deliberately stepped up slowly.

In the SURMOUNT-1 trial, people who stayed on treatment lost, on average, about a sixth of their body weight at the lowest maintenance dose and a little over a fifth at the highest dose, over 72 weeks.

Those are averages, not promises: some people lose more, some less.

The slow, modest first few weeks aren't a sign the medication is failing. They're how the treatment is designed to work.

How to read the numbers in this guide

Every figure below comes from a named clinical trial, and we've tried to translate each one into what it means for a real person.

Two things are worth noting:

  1. Trial figures are group averages. Your own result can land either side of them.
  2. The headline percentages are for people who stayed on treatment for the full study.
What's in this article

Before you read on

The most common concern we hear from people starting Mounjaro is: "I've had two injections, and nothing seems to be happening. Is this normal?”

If that's you, the short answer is yes, it very likely is.

The longer answer is what this article is for.

We'll walk through exactly what Mounjaro is doing in your body in the early weeks, how long it takes Mounjaro to work, what the clinical trial data shows about realistic timelines, and what you can do in the meantime to give the treatment the best possible chance.

Before you begin: A little bit about OnlineClinic

OnlineClinic has been operating since 2011 and has treated more than 2.1 million patients.

The pharmacy is registered with the General Pharmaceutical Council (GPhC), our prescribers are registered with the General Medical Council (GMC), and the service is regulated by the Care Quality Commission (CQC).

On Trustpilot, the service rating is 4.6 out of 5 based on 6,325 reviews as of July 2026.

If you're still weighing up whether Mounjaro is right for you, our Mounjaro vs Wegovy comparison covers the two leading weight loss medicines side by side.

Start free Mounjaro consultation

What to expect from Mounjaro in the early weeks

Before getting to the timeline, it helps to understand the mechanism.

Mounjaro's active ingredient, tirzepatide, activates two receptors simultaneously: GLP-1 and GIP.

Both are gut hormones involved in appetite, satiety, and blood sugar regulation.

When you inject Mounjaro, tirzepatide starts mimicking these receptors within hours.

The effects on appetite, such as reduced hunger, increased fullness after meals, quieter "food noise" between meals, often begin before any change in weight is visible.

Many people notice this shift in the first week or two.

The scales, though, take longer to catch up.

There are a few reasons for this.

First, your starting dose of 2.5mg is intentionally low.

Its job is to introduce your body to the medication and reduce the risk of side effects, not to achieve maximum appetite suppression.

Full appetite effects build as the dose increases.

Second, your body is making metabolic adjustments in the background that take weeks to translate into meaningful weight loss.

Third, water weight loss in the early weeks can temporarily look like actual fat loss on the scales.

None of this means the medication isn't working.

The simplest way to think about it

Mounjaro runs on two clocks that don't move together.

The appetite clock is what you feel — less hunger, smaller portions, quieter food noise — and it usually starts within days.

The scale clock is what you measure, and it's slower because fat loss takes time, and the early weeks are spent on a low starter dose.

When people worry Mounjaro "isn't working", they're almost always watching the scale clock while the appetite clock is already running.

If your appetite has changed, the medication is working. The weight loss is what that appetite change produces over the following weeks.

There's also a reason the effect often feels stronger from around week four.

Tirzepatide has a long half-life of roughly five days, so it builds up gradually within your body over your first several weekly injections rather than reaching full strength straight away.

By about four weeks, the medicine level in your body stops climbing and settles into a steady rhythm.

Doctors call this the steady state, where each weekly dose tops you back up to roughly the same level.

This is one reason the dose steps every four weeks: each new dose gets a chance to build up and settle before the next increase

To understand Mounjaro’s dosage schedule in detail, read our Mounjaro dosage guide.

Mounjaro week-by-week weight loss timeline: what the evidence shows

W1

Dose: 2.5mg

Days 1–7: first injection

Tirzepatide shows its effect roughly 8–72 hours after injection.

For most people, the clearest sign in week one is a change in appetite.

Food feels less appealing, portions feel more satisfying, and you do not feel hunger as strongly or as urgently as usual.

Visible weight change at this stage is unlikely.

The 2.5mg starting dose is the lowest in the dosage schedule and is primarily about tolerability.

W2–4

Dose: 2.5mg

Weeks 2–4: appetite settles

Appetite effects continue and tend to settle into a pattern.

Some people experience mild nausea or digestive changes in this period — this is the most common side effect of the starting dose.

For most, it eases within a few days of each injection.

For a full breakdown, see our guide on Mounjaro side effects.

You may notice some weight loss in this window, but results vary considerably.

The medication is doing its job even if the scales haven't shifted meaningfully yet.

W5–8

Dose: 5mg

Weeks 5–8: first dose increase

After four weeks, your prescriber will move you to 5mg — the first therapeutic increase.

For many people, this is when appetite suppression becomes more pronounced, and weight loss becomes more consistent.

The early weeks are the low end of the dose range, so the loss so far is usually modest — that's expected.

In the trials, the bulk of weight loss occurs later, as the dose increases over the following months.

W9–24

Dose: 7.5mg - 10mg

Weeks 9–24: titration and steady progress

This is the period when the dose escalation schedule does most of its work.

Doses step up from 5mg to 7.5mg, then to 10mg if tolerated, with each increase arriving after at least four weeks at the previous level.

Our Mounjaro dosage schedule guide covers this in more detail.

For most people, weeks 9 - 24 produce the most noticeable month-on-month progress.

The body has adapted to the medication, the dose is approaching therapeutic levels, and appetite suppression is at or near its peak.

A clinical trial shows that most participants who went on to achieve significant weight loss had crossed the 5% reduction threshold by week 24, even those who were slower responders in the first 12 weeks.

W25+

Dose: 12.5mg - 15mg

Weeks 25–72: maintenance and continued loss

The SURMOUNT-1 trial ran for 72 weeks.

Across all dose groups, participants continued to lose weight during this period, with the higher doses resulting in the greatest average weight loss.

Participants on a placebo lost far less on average, which is a good indication that the medication itself, not the diet advice alone, is doing most of the work.

Weight loss doesn't arrive in a straight line.

Most people experience faster progress in the middle months of treatment, followed by a temporary weight loss plateau.

Plateaus are a normal part of the process.

See our guide on Mounjaro weight loss plateau for what typically helps.

SURMOUNT-1 trial: average weight loss at 72 weeks

16.0%
at the 5mg dose
21.4%
at the 10mg dose
22.5%
at the 15mg dose
2.4%
on placebo (diet & activity alone)

In everyday terms: at the top dose, the average loss was a little over a fifth of starting body weight. For someone beginning at 16 stone (about 102 kg), that's roughly 3½ stone (around 23 kg) on average — though individual results ranged widely on either side.

Figures are the efficacy estimand (participants who stayed on treatment as intended); all also received diet and lifestyle support. Source: Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205–216. Counting everyone including those who stopped early, the averages were somewhat lower (15.0%, 19.5% and 20.9%).

Does slow weight loss mean failure?

A later analysis of the SURMOUNT-1 data examined separately those who saw little change in the first 12 weeks.

It sorted participants into early responders (who lost 5% or more weight by 12 weeks) and late responders (who lost less than 5% weight by 12 weeks).

About 18% of participants taking tirzepatide were late responders at the 12-week mark.

But the pattern it found is reassuring:

Key finding

By week 72, 90% of late responders had still achieved at least 5% weight loss.

The mean time for late responders to reach that threshold was around 25 weeks. Slower early progress did not predict poor long-term outcomes.

If your first few weeks have been underwhelming, this is worth knowing.

The trial data strongly support staying the course through the dose increases rather than stopping early.

What "not working" actually looks like

Slow early results are not the same as the medication not working. The signs that genuinely warrant a conversation with your prescriber are different:

Contact your prescriber if you notice

  • No change in appetite at all after two to three weeks at each dose. Some people experience minimal appetite suppression on lower doses but respond well once the dose increases. However, if there's no effect at all across multiple doses, your prescriber needs to know.
  • Weight continues to increase steadily after reaching a maintenance dose (10mg or 15mg), with no plateau or reduction.
  • Side effects are preventing dose progression. If nausea or other GI effects are severe enough to stop the dose increase, your prescriber can adjust the plan.

If your results feel slow, but you are noticing reduced appetite and some weight movement, the medication is almost certainly working.

Give the medicine some time to show its effect.

What you can do to support early results

Mounjaro works best when supported with dietary and lifestyle changes.

If you aren’t seeing much weight loss, or your weight loss has plateaued, here are some practical, day-to-day lifestyle and diet fixes that can help.

Eating patterns

Smaller meals, eaten slowly, work better with Mounjaro's delayed gastric emptying. Fatty or very rich foods tend to worsen nausea at lower doses. See our Mounjaro food guide.

Alcohol

GLP-1 medications can intensify alcohol's effects and may change how you tolerate it. Worth knowing before a social occasion. See our Mounjaro and alcohol guide.

Hydration

Nausea is more common when you're dehydrated, particularly in the first weeks of a new dose. Adequate water intake is a simple, practical way to reduce early side effects.

Movement

Regular activity, such as walking, cycling, or other sustainable activities, helps preserve lean muscle during weight loss. It doesn't need to be intense; consistency is what counts.

Weighing yourself

Weigh no more than once a week, at the same time of day. Day-to-day fluctuations reflect fluid and food weight, not fat change. Weekly trends are more informative.

Sleep

Poor sleep is associated with disrupted hunger hormones and slower weight loss. Getting consistent, adequate sleep supports the medication's appetite-regulating effects.

How does Mounjaro compare with other weight loss medicines?

The SURMOUNT-5 trial directly compared tirzepatide 15mg (Mounjaro) against semaglutide 2.4mg (Wegovy) over 72 weeks.

Tirzepatide participants lost an average of 20.2% of body weight, compared with 13.7% with semaglutide.

That said, the right treatment is the one that's clinically appropriate for you specifically.

If you want to compare both options in depth, our Mounjaro vs Wegovy guide covers mechanism, dosing, trial data, and eligibility in full.

When to contact your prescriber

You should get in touch if you experience any of the following:

  • Nausea, vomiting, or diarrhoea that is severe or isn't easing after the first week of a new dose
  • Persistent, severe abdominal pain that doesn't resolve (a possible sign of pancreatitis)
  • A significant and persistent increase in heart rate after injections
  • Any injection-site reaction that looks infected or doesn't settle within a few days
  • Several months at a maintenance dose with no appetite change and no weight movement

Your prescriber can review your progress, adjust your dose schedule, and decide whether to continue, pause, or change treatment.

At OnlineClinic, our prescribers are available throughout your treatment, and not just at the initial consultation.

What happens when you order

The process is straightforward from start to finish, and the same clinical team stays with you as you move up through the doses:

  1. Fill in a short medical questionnaire. It takes 5–10 minutes and covers your medical history, current medications, weight and height, and any conditions or allergies. The questions are thorough on purpose, so the prescriber can check if the treatment is safe for you.
  2. A GMC-registered prescriber reviews your answers. If they need more information, they message you through your account — no phone tag and no in-person visit.
  3. If the treatment is approved, it's dispensed and dispatched. You get next-day delivery in temperature-controlled packaging, along with the needles, a sharps bin and a patient information leaflet.
  4. If it isn't suitable, the prescriber tells you why and may suggest an alternative. You're not charged for treatment that isn't issued.

The same clinical team handles your dose increases and any reviews along the way, so there's always a GMC-registered prescriber overseeing your treatment as you increase your dose.

You can start with a free consultation — there's no charge for clinical advice or for a dose review.

Start your free Mounjaro consultation

Frequently asked questions

How quickly does Mounjaro suppress appetite?

I've had three injections, and my weight hasn't changed. Should I stop?

How much weight should I expect to lose in the first month?

Does Mounjaro start working straight away?

What if I'm an early responder — will my weight loss slow down?

Does a higher dose produce faster results?

I lost quickly in the first few weeks and then slowed down. Is that normal?

Can I do anything to speed up results?

How long will I need to stay on Mounjaro to maintain my results?

Is it normal to feel worse before I feel better?

Is OnlineClinic safe to use for Mounjaro?

Related guides

Trial evidence

  • Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205–216. doi:10.1056/NEJMoa2206038. Read the trial
  • Ard J, Lee CJ, Gudzune K, et al. Weight reduction over time in tirzepatide-treated participants by early weight loss response: post-hoc analysis in SURMOUNT-1. Diabetes, Obesity and Metabolism. 2025;27(9):5064–5071. doi:10.1111/dom.16554 (PMC12326891). Read the trial
  • Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine. 2025;393(1):26–36. doi:10.1056/NEJMoa2416394. Read the trial
  • Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945. Read the trial

UK regulatory and product information

Disclaimer

Mounjaro is a prescription-only medicine. Decisions about whether it's suitable for you, and about your dose, are made by a GMC-registered prescriber based on your individual medical history. This article is for general guidance only and does not constitute medical advice. Individual results vary. Suspected side effects can be reported through the MHRA Yellow Card scheme.

Further reading

Fill out a short
medical form
Select
medication
Doctor issues
prescription
Medication sent
from pharmacy